Topics

Trump’s Plan To Lower Drug Prices By Targeting Rebates Would Cost Taxpayers $177 Billion

08:51 EDT 3 May 2019 | Kaiser Health News

The Congressional Budget Office concluded that a proposal to curtail rebates in the drug system is unlikely to force drug companies to lower list prices across the board. Instead, they would reimburse pharmacies for discounts provided to individual seniors as they fill their prescriptions. In other pharmaceutical news: an aspiring drugmaker's battle with federal regulators, Cigna's strong performance in the pharmacy-benefits business, and more.

Original Article: Trump’s Plan To Lower Drug Prices By Targeting Rebates Would Cost Taxpayers $177 Billion

NEXT ARTICLE

More From BioPortfolio on "Trump’s Plan To Lower Drug Prices By Targeting Rebates Would Cost Taxpayers $177 Billion"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...